Monte Rosa Therapeutics stock forecast
Want to see GLUE full AI Analyst Report?
Monte Rosa Therapeutics (GLUE) Stock Forecast & Price Target
GLUE Analyst Ratings
GLUE Stock 12 Month Forecast
Average Price Target
$25.14▲(168.33% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Edward Tenthoff | Piper Sandler | $37 | buy | 294.88%Upside | Reiterated | 11/10/26 | ||
| Mitchell Kapoor | H.C. Wainwright | $25 | buy | 166.81%Upside | Reiterated | 11/06/26 | ||
| Derek Archila | Wells Fargo | $27→$25 | buy | 166.81%Upside | Assigned | 11/06/26 | ||
| Robert Driscoll | Wedbush | $27 | buy | 188.15%Upside | Reiterated | 11/06/26 | ||
| Faisal Khurshid | Jefferies | $25→$15 | buy | 60.09%Upside | Reiterated | 11/05/26 | ||
| Michael Schmidt | Guggenheim | $28 | buy | 198.83%Upside | Reiterated | 11/05/26 | ||
| Alice Nettleton | UBS | $17→$19 | buy | 102.77%Upside | Initiated | 10/12/26 | ||
| Oliver McCammon | LifeSci Capital | ― | buy | ― | Reiterated | 10/02/26 | ||
| Brian Cheng | J.P. Morgan | $27 | buy | 188.15%Upside | Reiterated | 08/10/26 | ||
| Marc Frahm | TD Cowen | ― | buy | ― | Reiterated | 05/07/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Edward TenthoffPiper Sandler | BuyReiterated$37 | 11/10/26 | 294.88%Upside | ||
| Mitchell KapoorH.C. Wainwright | BuyReiterated$25 | 11/06/26 | 166.81%Upside | ||
| Derek ArchilaWells Fargo | BuyAssigned$27→$25 | 11/06/26 | 166.81%Upside | ||
| Robert DriscollWedbush | BuyReiterated$27 | 11/06/26 | 188.15%Upside | ||
| Faisal KhurshidJefferies | BuyReiterated$25→$15 | 11/05/26 | 60.09%Upside | ||
| Michael SchmidtGuggenheim | BuyReiterated$28 | 11/05/26 | 198.83%Upside | ||
| Alice NettletonUBS | BuyInitiated$17→$19 | 10/12/26 | 102.77%Upside | ||
| Oliver McCammonLifeSci Capital | BuyReiterated | 10/02/26 | ― | ||
| Brian ChengJ.P. Morgan | BuyReiterated$27 | 08/10/26 | 188.15%Upside | ||
| Marc FrahmTD Cowen | BuyReiterated | 05/07/26 | ― |
Best Analysts Covering Monte Rosa Therapeutics
Copying Marc Frahm's trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +29.29% per trade.
Copying Marc Frahm's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +47.67% per trade.
Copying Marc Frahm's trades and holding each position for 2 Years would result in 56.25% of your transactions generating a profit, with an average return of +80.69% per trade.
GLUE Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 5 | 8 | 10 | 14 | 13 |
| Buy | 6 | 5 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 13 | 14 | 17 | 16 |
In the current month, GLUE has received 16 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GLUE average Analyst price target in the past 3 months is 25.14.
GLUE Financial Forecast
GLUE Earnings Forecast
Next quarter’s earnings estimate for GLUE is -$0.21 with a range of -$0.58 to $0.58. The previous quarter’s EPS was $0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
GLUE Sales Forecast
Next quarter’s sales forecast for GLUE is $35.66M with a range of $0 to $123.00M. The previous quarter’s sales results were $54.37M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
